Nicholas Latchana1, Kelly Regan2, J Harrison Howard1, Jennifer H Aldrink3, Mark A Ranalli4, Sara B Peters5, Xiaoli Zhang6, Alejandro Gru7, Philip R O Payne2, Lorena P Suarez-Kelly8, William E Carson1,8. 1. Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH. 2. Department of Biomedical Informatics, The Ohio State University, Columbus, OH. 3. Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH. 4. Department of Hematology/Oncology, Nationwide Children's Hospital, Columbus, OH. 5. Department of Pathology, The Ohio State University, Columbus, OH. 6. Center for Biostatistics, The Ohio State University, Columbus, OH. 7. Department of Pathology, University of Virgina, Charlottesville, VA. 8. Department of Molecular Virology, Immunology and Medical Genetics, The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.
Abstract
BACKGROUND: Melanoma skin cancer remains the leading cause of skin cancer-related deaths. Spitz lesions represent a subset of melanocytic skin lesions characterized by epithelioid or spindled melanocytes organized in nests. These lesions occupy a spectrum ranging from benign Spitz and atypical Spitz lesions all the way to malignant Spitz tumors. Appropriate management is reliant on accurate diagnostic classification, yet this effort remains challenging using current light microscopic techniques. The discovery of novel biomarkers such as microRNAs (miR) may ultimately be a useful diagnostic adjunct for the evaluation of Spitz lesions. miR expression profiles have been suggested for non-Spitz melanomas but have yet to be ascribed to Spitz lesions. We hypothesized that distinct miR expression profiles would be associated with different lesions along the Spitz spectrum. MATERIALS AND METHODS: RNAs extracted from paraffin-embedded, formalin-fixed tissues of 11 resected skin lesions including benign nevi (n = 2), benign Spitz lesions (n = 3), atypical Spitz lesions (n = 3), and malignant Spitz tumors (n = 3) were analyzed by the NanoString platform for simultaneous evaluation of over 800 miRs in each patient sample. RESULTS: Benign Spitz lesions had increased expression of miR-21-5p and miR-363-3p compared with those of benign nevi. Malignant Spitz lesions exhibited overexpression of miR-21-5p, miR-155-5p, and miR-1283 relative to both benign nevi and benign Spitz tumors. Notably, atypical Spitz tumors had increased expression of miR-451a and decreased expression of miR-155-5p expression relative to malignant Spitz lesions. Conversely, atypical Spitz lesions had increased expression of miR-21-5p, miR-34a-5p, miR-451a, miR-1283, and miR-1260a relative to benign Spitz tumors. CONCLUSIONS: Overall, distinct miR profiles are suggested among Spitz lesions of varying malignant potential with some similarities to non-Spitz melanoma tumors. This work demonstrates the feasibility of this analytic method and forms the basis for further validation studies.
BACKGROUND:Melanoma skin cancer remains the leading cause of skin cancer-related deaths. Spitz lesions represent a subset of melanocytic skin lesions characterized by epithelioid or spindled melanocytes organized in nests. These lesions occupy a spectrum ranging from benign Spitz and atypical Spitz lesions all the way to malignant Spitz tumors. Appropriate management is reliant on accurate diagnostic classification, yet this effort remains challenging using current light microscopic techniques. The discovery of novel biomarkers such as microRNAs (miR) may ultimately be a useful diagnostic adjunct for the evaluation of Spitz lesions. miR expression profiles have been suggested for non-Spitz melanomas but have yet to be ascribed to Spitz lesions. We hypothesized that distinct miR expression profiles would be associated with different lesions along the Spitz spectrum. MATERIALS AND METHODS: RNAs extracted from paraffin-embedded, formalin-fixed tissues of 11 resected skin lesions including benign nevi (n = 2), benign Spitz lesions (n = 3), atypical Spitz lesions (n = 3), and malignant Spitz tumors (n = 3) were analyzed by the NanoString platform for simultaneous evaluation of over 800 miRs in each patient sample. RESULTS: Benign Spitz lesions had increased expression of miR-21-5p and miR-363-3p compared with those of benign nevi. Malignant Spitz lesions exhibited overexpression of miR-21-5p, miR-155-5p, and miR-1283 relative to both benign nevi and benign Spitz tumors. Notably, atypical Spitz tumors had increased expression of miR-451a and decreased expression of miR-155-5p expression relative to malignant Spitz lesions. Conversely, atypical Spitz lesions had increased expression of miR-21-5p, miR-34a-5p, miR-451a, miR-1283, and miR-1260a relative to benign Spitz tumors. CONCLUSIONS: Overall, distinct miR profiles are suggested among Spitz lesions of varying malignant potential with some similarities to non-Spitz melanoma tumors. This work demonstrates the feasibility of this analytic method and forms the basis for further validation studies.
Authors: Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns Journal: Cancer Biol Ther Date: 2013-12-18 Impact factor: 4.742
Authors: Mathew W Ludgate; Douglas R Fullen; Julia Lee; Lori Lowe; Carol Bradford; James Geiger; Jennifer Schwartz; Timothy M Johnson Journal: Cancer Date: 2009-02-01 Impact factor: 6.860
Authors: Iwona Nowak; Elżbieta Boratyn; Sebastian Student; Stephan F Bernhart; Jörg Fallmann; Małgorzata Durbas; Peter F Stadler; Hanna Rokita Journal: RNA Biol Date: 2020-08-20 Impact factor: 4.652
Authors: Juan de Los Santos-Jiménez; José A Campos-Sandoval; Clara Márquez-Torres; Nieves Urbano-Polo; David Brøndegaard; Mercedes Martín-Rufián; Carolina Lobo; Ana Peñalver; María C Gómez-García; Janet Martín-Campos; Carolina Cardona; Laura Castilla; Felipe da Costa Souza; Tzuling Cheng; Juan A Segura; Francisco J Alonso; Rui Curi; Alison Colquhoun; Ralph J DeBerardinis; Javier Márquez; José M Matés Journal: J Biomed Sci Date: 2021-02-20 Impact factor: 8.410